Whole-exome sequencing of the NSCLC lines revealed a significant concordance between an NSCLC’s capacity to induce cachexia in vivo and the presence of tumor serine/threonine kinase 11 (STK11/LKB1) loss-of-function variants. This evidence concerns the gene STK11 and non-small cell lung carcinoma.